WallStreetZenWallStreetZen

NASDAQ: FIXX
Homology Medicines Inc Stock Ownership - Who owns Homology Medicines?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Homology Medicines Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Albert SeymourPresident and Chief Executive Officer2023-09-061,448$1.15
$1.67kSell
Julie JordanChief Medical Officer2023-08-03436$1.39
$606.04Sell
Julie JordanChief Medical Officer2023-08-031,308$1.39
$1.82kSell
Julie JordanChief Medical Officer2023-08-03109$1.39
$151.51Sell
Julie JordanChief Medical Officer2023-08-0299$1.31
$129.69Sell
Paul AllowayChief Legal Officer and Secretary2023-03-0210,965$1.45
$15.87kSell
Arthur TzianabosDirector2023-01-0910,616$1.39
$14.77kSell
Michael Lee BlumChief Commercial Officer2023-01-092,454$1.39
$3.41kSell
Albert SeymourPresident and Chief Executive Officer2023-01-093,620$1.39
$5.03kSell
W. Bradford SmithChief Financial and Business Officer and Treasurer2023-01-093,729$1.39
$5.19kSell

1 of 2

FIXX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FIXX insiders and whales buy or sell their stock.

FIXX Shareholders

What type of owners hold Homology Medicines Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Arch Venture Fund Viii LP9.96%5,768,694$3.21MInsider
Temasek Holdings Private Ltd9.75%5,650,996$3.15MInstitution
5am Venture Management LLC7.83%4,535,919$2.53MInstitution
James E. Flynn7.06%4,087,305$2.28MInsider
Vanguard Group Inc3.53%2,046,442$1.14MInstitution
Blackrock Inc1.91%1,106,288$616.20kInstitution
Mahendra Shah1.57%909,742$506.73kInsider
Citadel Advisors LLC1.52%879,112$489.67kInstitution
Vivo Capital LLC0.64%370,068$206.13kInstitution
Geode Capital Management LLC0.56%323,459$180.17kInstitution

1 of 3

FIXX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FIXX29.79%20.14%Net Selling
CLRB11.87%33.00%
SLGL28.86%0.00%
ENLV1.39%77.27%
INAB7.74%15.44%Net BuyingNet Buying
View Top Biotech Stocks

Homology Medicines Stock Ownership FAQ

Who owns Homology Medicines?

Homology Medicines (NASDAQ: FIXX) is owned by 29.79% institutional shareholders, 20.14% Homology Medicines insiders, and 50.06% retail investors. Arch Venture Fund Viii LP is the largest individual Homology Medicines shareholder, owning 5.77M shares representing 9.96% of the company. Arch Venture Fund Viii LP's Homology Medicines shares are currently valued at $3.21M.

If you're new to stock investing, here's how to buy Homology Medicines stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.